These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1789569)

  • 41. Identification of GTP-binding proteins in myelin and oligodendrocyte membranes.
    Braun PE; Horvath E; Yong VW; Bernier L
    J Neurosci Res; 1990 May; 26(1):16-23. PubMed ID: 2113588
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The molecular architecture of myelin: identification of the external surface membrane components.
    Poduslo JF
    Adv Exp Med Biol; 1978; 100():189-205. PubMed ID: 696473
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of post-mitotic oligodendrocytes incapable of remyelination within the demyelinated adult spinal cord.
    Keirstead HS; Blakemore WF
    J Neuropathol Exp Neurol; 1997 Nov; 56(11):1191-201. PubMed ID: 9370229
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Novel molecular insights into the critical role of sulfatide in myelin maintenance/function.
    Palavicini JP; Wang C; Chen L; Ahmar S; Higuera JD; Dupree JL; Han X
    J Neurochem; 2016 Oct; 139(1):40-54. PubMed ID: 27417284
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prolonged Sox4 expression in oligodendrocytes interferes with normal myelination in the central nervous system.
    Potzner MR; Griffel C; Lütjen-Drecoll E; Bösl MR; Wegner M; Sock E
    Mol Cell Biol; 2007 Aug; 27(15):5316-26. PubMed ID: 17515609
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Incorporation of radioactivity from U-14C-glucose into oligodendrocytes and myelin of quaking mice and their littermate controls.
    Chao SW; Bourre JM
    Dev Neurosci; 1986; 8(2):117-24. PubMed ID: 3743469
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dysmyelination and reduced myelin basic protein gene expression by oligodendrocytes of SHP-1-deficient mice.
    Massa PT; Wu C; Fecenko-Tacka K
    J Neurosci Res; 2004 Jul; 77(1):15-25. PubMed ID: 15197735
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The number of cells expressing the myelin-supporting oligodendrocyte marker PLP-exon 3b remains unchanged in Wallerian degeneration.
    Li G; Blakemore WF
    J Neurotrauma; 2004 Aug; 21(8):1044-9. PubMed ID: 15319003
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fibroblast growth factor-2 inhibits myelin production by oligodendrocytes in vivo.
    Goddard DR; Berry M; Kirvell SL; Butt AM
    Mol Cell Neurosci; 2001 Nov; 18(5):557-69. PubMed ID: 11922145
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An in-vitro approach to the study of oligodendrocytes and their involvement in multiple sclerosis.
    Szuchet S; Dumas M
    Neurol Clin; 1983 Aug; 1(3):729-55. PubMed ID: 6680171
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Silencing of Nogo-A in rat oligodendrocyte cultures enhances process branching.
    Zhao X; Wu J; Kuang F; Wang J; Ju G
    Neurosci Lett; 2011 Jul; 499(1):32-6. PubMed ID: 21624429
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of an intronic enhancer that regulates myelin proteolipid protein (Plp) gene expression in oligodendrocytes.
    Meng F; Zolova O; Kokorina NA; Dobretsova A; Wight PA
    J Neurosci Res; 2005 Nov; 82(3):346-56. PubMed ID: 16155935
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Carbohydrate-coated fluorescent silica nanoparticles as probes for the galactose/3-sulfogalactose carbohydrate-carbohydrate interaction using model systems and cellular binding studies.
    Zhao J; Liu Y; Park HJ; Boggs JM; Basu A
    Bioconjug Chem; 2012 Jun; 23(6):1166-73. PubMed ID: 22551003
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Myelination and motor coordination are increased in transferrin transgenic mice.
    Saleh MC; Espinosa de los Monteros A; de Arriba Zerpa GA; Fontaine I; Piaud O; Djordjijevic D; Baroukh N; Garcia Otin AL; Ortiz E; Lewis S; Fiette L; Santambrogio P; Belzung C; Connor JR; de Vellis J; Pasquini JM; Zakin MM; Baron B; Guillou F
    J Neurosci Res; 2003 Jun; 72(5):587-94. PubMed ID: 12749023
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An autoradiographic study of cellular proliferation in remyelination of the central nervous system.
    Ludwin SK
    Am J Pathol; 1979 Jun; 95(3):683-96. PubMed ID: 453329
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Toll-like receptor 4 participates in the myelin disruptions associated with chronic alcohol abuse.
    Alfonso-Loeches S; Pascual M; Gómez-Pinedo U; Pascual-Lucas M; Renau-Piqueras J; Guerri C
    Glia; 2012 May; 60(6):948-64. PubMed ID: 22431236
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Localisation and expression of a myelin associated neurite inhibitor, Nogo-A and its receptor Nogo-receptor by mammalian CNS cells.
    Nyatia E; Lang DM
    Res Vet Sci; 2007 Dec; 83(3):287-301. PubMed ID: 17428512
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fate of oligodendrocytes during retinal axon degeneration and regeneration in the goldfish visual pathway.
    Ankerhold R; Stuermer CA
    J Neurobiol; 1999 Dec; 41(4):572-84. PubMed ID: 10590180
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sox8 and Sox10 jointly maintain myelin gene expression in oligodendrocytes.
    Turnescu T; Arter J; Reiprich S; Tamm ER; Waisman A; Wegner M
    Glia; 2018 Feb; 66(2):279-294. PubMed ID: 29023979
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vitro analysis of the oligodendrocyte lineage in mice during demyelination and remyelination.
    Armstrong R; Friedrich VL; Holmes KV; Dubois-Dalcq M
    J Cell Biol; 1990 Sep; 111(3):1183-95. PubMed ID: 2167897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.